These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 19116965

  • 1. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
    van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Ewals JA, Han KH, Hazes JM, Kerstens PJ, Peeters AJ, van Zeben D, Breedveld FC, Huizinga TW, Dijkmans BA, Allaart CF.
    Arthritis Rheum; 2009 Jan 15; 61(1):4-12. PubMed ID: 19116965
    [Abstract] [Full Text] [Related]

  • 2. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, Dorrier C, Thompson A.
    Arthritis Rheum; 2000 Mar 15; 43(3):506-14. PubMed ID: 10728742
    [Abstract] [Full Text] [Related]

  • 3. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.
    Allaart CF, Breedveld FC, Dijkmans BA.
    J Rheumatol Suppl; 2007 Nov 15; 80():25-33. PubMed ID: 17985420
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.
    Rigby W, Ferraccioli G, Greenwald M, Zazueta-Montiel B, Fleischmann R, Wassenberg S, Ogale S, Armstrong G, Jahreis A, Burke L, Mela C, Chen A.
    Arthritis Care Res (Hoboken); 2011 May 15; 63(5):711-20. PubMed ID: 21557525
    [Abstract] [Full Text] [Related]

  • 8. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V, Tugwell P, Bombardier C, Maetzel A, Crawford B, Dorrier C, Thompson A, Wells G.
    Arthritis Rheum; 1999 Sep 15; 42(9):1870-8. PubMed ID: 10513801
    [Abstract] [Full Text] [Related]

  • 9. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.
    van Riel PL, Freundlich B, MacPeek D, Pedersen R, Foehl JR, Singh A, ADORE Study Investigators.
    Ann Rheum Dis; 2008 Aug 15; 67(8):1104-10. PubMed ID: 17666447
    [Abstract] [Full Text] [Related]

  • 10. Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial.
    Klarenbeek NB, van der Kooij SM, Huizinga TJ, Goekoop-Ruiterman YP, Hulsmans HM, van Krugten MV, Speyer I, de Vries-Bouwstra JK, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.
    Ann Rheum Dis; 2010 Jul 15; 69(7):1342-5. PubMed ID: 20472597
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.
    Strand V, Rentz AM, Cifaldi MA, Chen N, Roy S, Revicki D.
    J Rheumatol; 2012 Jan 15; 39(1):63-72. PubMed ID: 22045836
    [Abstract] [Full Text] [Related]

  • 15. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M.
    Arthritis Rheum; 2004 Jan 15; 50(1):55-62. PubMed ID: 14730599
    [Abstract] [Full Text] [Related]

  • 16. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
    Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR.
    Arthritis Rheum; 2008 May 15; 58(5):1310-7. PubMed ID: 18438851
    [Abstract] [Full Text] [Related]

  • 17. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ, Isern RA, Cooley DA, Harshbarger JL, Huffstutter JE, Hughes GM, Spencer-Smith EA, Goldman AL, Roth SH, Toder JS, Warner D, Quinn A, Keenan GF, Schaible TF, PROMPT Study Group. Profiling Remicade Onset with MTX in a Prospective Trial.
    J Rheumatol; 2002 Apr 15; 29(4):667-77. PubMed ID: 11950005
    [Abstract] [Full Text] [Related]

  • 18. Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years.
    Strand V, Balbir-Gurman A, Pavelka K, Emery P, Li N, Yin M, Lehane PB, Agarwal S.
    Rheumatology (Oxford); 2006 Dec 15; 45(12):1505-13. PubMed ID: 17062648
    [Abstract] [Full Text] [Related]

  • 19. Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
    Strand V, Scott DL, Emery P, Kalden JR, Smolen JS, Cannon GW, Tugwell P, Crawford B, Leflunomide Rheumatoid Arthritis Investigators Groups.
    J Rheumatol; 2005 Apr 15; 32(4):590-601. PubMed ID: 15801012
    [Abstract] [Full Text] [Related]

  • 20. Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial).
    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, Kerstens PJ, Grillet BA, de Jager MH, Han KH, Speyer I, van der Lubbe PA, Seys PE, Breedveld FC, Dijkmans BA.
    Ann Rheum Dis; 2007 Sep 15; 66(9):1227-32. PubMed ID: 17405834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.